Based on previous work reported by our group, and supported by others, nuclear factor kappa B (NF-κB) appears to be a central molecular player in PCa progression and may represent a potential prognostic biomarker [3-9]. This evidence concerns the gene NFKB1 and posterior cortical atrophy.